(NYSE: ALB) Albemarle's forecast annual revenue growth rate of -3.9% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.18%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.63%.
Albemarle's revenue in 2024 is $7,457,882,000.On average, 7 Wall Street analysts forecast ALB's revenue for 2024 to be $653,184,959,318, with the lowest ALB revenue forecast at $619,517,681,685, and the highest ALB revenue forecast at $699,512,094,292. On average, 7 Wall Street analysts forecast ALB's revenue for 2025 to be $691,055,578,033, with the lowest ALB revenue forecast at $533,013,220,725, and the highest ALB revenue forecast at $812,684,493,673.
In 2026, ALB is forecast to generate $791,646,514,741 in revenue, with the lowest revenue forecast at $726,355,392,300 and the highest revenue forecast at $926,327,025,995.